Trial intelligence / Profile preview

Dopamine modulation of memory and reward in healthy volunteers

NL-OMON58337Not yet recruiting

Sponsor
Centre for Human Drug Research
Start
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of amisulpride, modafinil and Placebo-COD Research Private Ltd, sponsored by Centre for Human Drug Research. Primary endpoints: Effect of single oral doses of amisulpride and modafinil on novelty-induced memory performance and Effect of single oral doses of amisulpride and modafinil on reward valuation and reward sensitivity using the Grip Effort Task. Planned start Feb 2026; status: not yet recruiting.

02

Drugs

amisulpridemodafinilPlacebo-COD Research Private Ltd

Beyond the preview

Go deeper on NL-OMON58337.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON58337.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call